Financials

Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2823
IMMX
Immix Biopharma, Inc. - Common Stock
10.68 USD+1.52%-8.87%+25.65%+278.72%581.11 M USD
2842
ALT
Altimmune, Inc. - Common Stock
2.93 USD-2.01%-0.34%+10.57%-30.24%569.81 M USD
2851
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
9.05 USD-0.11%+0.11%+11.32%+1.91%564.04 M USD
2883
ARVN
Arvinas, Inc. - Common Stock
8.27 USD+2.10%-2.13%+10.71%-11.08%533.59 M USD

Frequently asked questions about Bright Minds Biosciences Inc. - common stock

What is the Bright Minds Biosciences Inc. - common stock stock price today?

The current price of Bright Minds Biosciences Inc. - common stock (DRUG) is 74.03. Over the past 24 hours, the stock has changed by -2.50%. Follow the DRUG chart for real-time price dynamics.

What is the stock ticker of Bright Minds Biosciences Inc. - common stock?

Bright Minds Biosciences Inc. - common stock trades under the ticker DRUG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bright Minds Biosciences Inc. - common stock stock going up?

DRUG has changed by +16.69% over the last week, +24.25% over the last month, and +198.87% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Bright Minds Biosciences Inc. - common stock have?

As of the latest available data, Bright Minds Biosciences Inc. - common stock has 25 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Bright Minds Biosciences Inc. - common stock stock?

You can buy Bright Minds Biosciences Inc. - common stock (DRUG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bright Minds Biosciences Inc. - common stock stock?

Investing in Bright Minds Biosciences Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DRUG chart and related analysis on metatrader.com as part of your research.

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use. It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens. The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York.

News